Fingerprint
Dive into the research topics of 'Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
PACIFIC Investigators
Research output: Contribution to journal › Article › peer-review
1700
Citations
(Scopus)